DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Thompson PA, O'Brien SM, Wierda WG, Ferrajoli A, Stingo F, Smith SC. et al.
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.
Cancer 2015;
121: 3612-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.